Strengthening the European Psychedelic Ecosystem: Partnership Between Octarine Bio and Clerkenwell Health
The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe. Clerkenwell Health … Continued
